OneMedNet Corporation ONMD
0.65
(0.06)
(8.45%)
as of 25 Sep
- Market cap
- $41.8M
- P/E
- 0.0×
Follow ONMD
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
28.31 | 35.67 | 36.06 | 115.87 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(21.97) | (30.49) | (28.61) | (32.83) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
28.55 | 36.08 | 35.97 | 118.73 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(6.04) | (6.61) | (6.52) | (7.55) | |
EV/FCF |
(6.03) | (6.60) | (6.50) | (7.51) | |
Quick Ratio |
0.22 | 0.19 | 0.33 | 0.27 | |
Current Ratio |
0.28 | 0.27 | 0.43 | 0.29 | |
Net Debt/EBITDA |
(0.15) | (0.21) | 0.04 | 0.16 | |
Debt/Assets |
51.39% | 55.54% | 45.28% | 25.76% | |
Debt/Equity |
(0.20) | (0.21) | (0.33) | (0.10) | |
Asset Turnover |
0.79 | 0.81 | 0.46 | 0.17 | |
Operating CF/Net income |
0.86 | 0.63 | 0.55 | 2.36 | |
Capex/Depreciation |
(1.80) | (0.18) | (0.56) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
110.96% | 323.96% | 51.91% | 182.49% | |
Selling, General and Administrative Expense of Revenue |
469.86% | 1,938.54% | 322.13% | 954.80% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
158.56% | 448.96% | 166.85% | 80.23% | |
Graham Net Nets |
(0.09) | (0.09) | (0.06) | (0.07) | |
Graham Number |
0.47 | 0.30 | 0.33 | 0.30 | |
Earnings Yield |
(23.11%) | (6.36%) | (6.74%) | (4.96%) | |
Free Cash Flow Yield |
(16.73%) | (15.32%) | (15.34%) | (13.65%) | |
Revenue per Share |
0.01 | 0.00 | 0.02 | 0.00 | |
Operating CF per Share |
(0.03) | (0.03) | (0.04) | (0.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.03) | (0.04) | (0.03) | |
Cash per Share |
0.01 | 0.01 | 0.02 | 0.01 | |
Shareholders Equity per Share |
(0.06) | (0.07) | (0.07) | (0.07) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.06) | (0.07) | (0.07) | (0.07) | |
Free Cash Flow |
(1.88) | (1.54) | (1.72) | (1.75) | |
Working Capital |
(3.41) | (3.89) | (2.73) | (3.56) | |
Capital Expenditures |
(0.01) | 0.00 | 0.00 | 0.00 | |
Net Current Asset Value |
(3.57) | (4.13) | (3.02) | (4.00) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.02 | 0.01 | 0.00 | |
Net Profit Margin |
(743.84%) | (2,555.21%) | (352.81%) | (418.64%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.46 | 0.47 | 0.35 | 0.32 | |
Average Payables |
4.36 | 5.41 | 4.77 | 5.00 | |
Average Assets |
1.85 | 1.62 | 2.94 | 2.95 | |
Average Common Equity |
(3.68) | (10.31) | (9.46) | (9.10) |
Columns are period end dates